Fate Therapeutics, Inc. Share Price
FATEFate Therapeutics, Inc. Stock Performance
Open $1.20 | Prev. Close $1.19 | Circuit Range N/A |
Day Range $1.20 - $1.29 | Year Range $0.83 - $1.93 | Volume 56,398 |
Average Traded $1.27 |
Fate Therapeutics, Inc. Share Price Chart
About Fate Therapeutics, Inc.
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Fate Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Apr-26 | $1.20 | $1.27 | +0.00% |
09-Apr-26 | $1.20 | $1.27 | +7.14% |
08-Apr-26 | $1.22 | $1.19 | +2.15% |
07-Apr-26 | $1.20 | $1.17 | -2.51% |
06-Apr-26 | $1.23 | $1.20 | -1.65% |
02-Apr-26 | $1.20 | $1.22 | -1.62% |
01-Apr-26 | $1.23 | $1.24 | +2.49% |
FAQs on Fate Therapeutics, Inc. Share Price
Can I buy Fate Therapeutics, Inc. shares in India?
What is the share price of Fate Therapeutics, Inc.?
What is the 5 year returns of Fate Therapeutics, Inc.?
What are the high & low stock price of Fate Therapeutics, Inc. today?
What is the 52-week high and low of Fate Therapeutics, Inc. stock?